[Delayed delivery in a triplet pregnancy--a case report]
Ginekologia Polska
|July 18, 2014
Summary
Delayed delivery in a triplet pregnancy is possible with interventions like bed rest and steroids. This case highlights a successful 18-day delay, though only one infant survived with normal development.
Area of Science:
- Perinatology
- Reproductive Medicine
- Maternal-Fetal Medicine
Background:
- Multiple pregnancies, particularly those resulting from in vitro fertilization (IVF), present unique challenges in managing delivery timing.
- Strategies to delay delivery in multiple gestations include bed rest, antibiotics, tocolytics, and steroids, alongside careful maternal and fetal monitoring.
- Preventing intra-amniotic infection is crucial during delayed delivery attempts in multiple pregnancies.
Observation:
- This report details a rare case of a trichorionic, triamniotic triplet pregnancy conceived via IVF.
- The initial two fetuses were delivered spontaneously at 23 and 26 weeks' gestation.
- The third fetus was delivered via cesarean section at 26 weeks, resulting in an 18-day interval between the first and subsequent deliveries.
Findings:
- Despite the significant delay between births, only the second infant survived.
- The surviving infant, delivered at 26 weeks gestation, exhibits normal psychomotor development at present.
- The case demonstrates the potential for delayed delivery in extreme preterm multiple gestations, albeit with significant risks.
Implications:
- This case underscores the complex decision-making involved in managing extremely preterm multiple births and the potential, though limited, for inter-delivery interval extension.
- Further research is warranted to optimize interventions for delaying delivery in multifetal gestations and improving neonatal outcomes.
- Careful monitoring of clinical and laboratory parameters is essential to mitigate complications such as intra-amniotic infection during delayed delivery scenarios.
Related Concept Videos
Intrauterine Drug Delivery Systems
164
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
164
Mitral Valve Prolapse III: Nursing Management
570
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
570
Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K


